Search Results - "Brouwers, Martijn C"

Refine Results
  1. 1

    Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality by Brouwers, Martijn C. G. J., Simons, Nynke, Stehouwer, Coen D. A., Isaacs, Aaron

    Published in Diabetologia (01-02-2020)
    “…Non-alcoholic fatty liver disease (NAFLD) is highly prevalent among individuals with type 2 diabetes. Although epidemiological studies have shown that NAFLD is…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Association of common gene variants in glucokinase regulatory protein with cardiorenal disease: A systematic review and meta-analysis by Simons, Pomme I H G, Simons, Nynke, Stehouwer, Coen D A, Schalkwijk, Casper G, Schaper, Nicolaas C, Brouwers, Martijn C G J

    Published in PloS one (23-10-2018)
    “…Small-molecules that disrupt the binding between glucokinase and glucokinase regulatory protein (GKRP) in the liver represent a potential new class of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Towards precision medicine in diabetes? A critical review of glucotypes by Hulman, Adam, Foreman, Yuri D, Brouwers, Martijn C G J, Kroon, Abraham A, Reesink, Koen D, Dagnelie, Pieter C, van der Kallen, Carla J H, Greevenbroek, Marleen M J van, Færch, Kristine, Vistisen, Dorte, Jørgensen, Marit E, Stehouwer, Coen D A, Witte, Daniel R

    Published in PLoS biology (11-03-2021)
    “…In response to a study previously published in PLOS Biology, this Formal Comment thoroughly examines the concept of 'glucotypes' with regard to its…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Thiazolidinediones and Glucagon‐Like Peptide‐1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study by Dalem, Judith, Driessen, Johanna H. M., Burden, Andrea M., Stehouwer, Coen D. A., Klungel, Olaf H., Vries, Frank, Brouwers, Martijn C. G. J.

    Published in Hepatology (Baltimore, Md.) (01-11-2021)
    “…Background and Aims Thiazolidinediones (TZDs) and glucagon‐like peptide‐1 (GLP‐1) receptor agonists are potential pharmacological treatment options for…”
    Get full text
    Journal Article
  13. 13

    Relevant patient characteristics for estimating healthcare needs according to healthcare providers and people with type 2 diabetes: a Delphi survey by Hertroijs, Dorijn F L, Brouwers, Martijn C G J, Elissen, Arianne M J, Schaper, Nicolaas C, Ruwaard, Dirk

    Published in BMC health services research (16-08-2019)
    “…Recently, there has been growing interest in providing more tailored, patient-centered care for the treatment of type 2 diabetes mellitus (T2DM). Yet it…”
    Get full text
    Journal Article
  14. 14

    The association of type 2 diabetes‐related characteristics with fracture risk at different sites by Hulten, Veerle, Souverein, Patrick C., Starup‐Linde, Jakob, Viggers, Rikke, Klungel, Olaf H., Vestergaard, Peter, Brouwers, Martijn C. J. G., Bergh, Joop P., Driessen, Johanna H. M.

    Published in Diabetes, obesity & metabolism (01-11-2024)
    “…Aim To determine the association of diabetes‐related characteristics with fractures at different sites in individuals with type 2 diabetes (T2D). Materials and…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Causal relationship between polycystic ovary syndrome and coronary artery disease: A Mendelian randomisation study by Simons, Pomme I. H. G., Cornelissen, Merel E. B., Valkenburg, Olivier, Onland‐Moret, N. Charlotte, Schouw, Yvonne T., Stehouwer, Coen D.A., Burgess, Stephen, Brouwers, Martijn C. G. J.

    Published in Clinical endocrinology (Oxford) (01-04-2022)
    “…Objective Polycystic ovary syndrome (PCOS) has been associated with an increased risk of coronary artery disease (CAD). However, it remains uncertain whether…”
    Get full text
    Journal Article
  19. 19
  20. 20